Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...

Educating physicians about PSA reduction goals may increase the number of patients with mCSPC receiving first-line treatment ...

The WOLVERINE study analyzed five trials and found metastasis-directed therapy -- primarily radiation -- may delay castration resistance and improve other long-term outcomes in prostate cancer. While ...

Researchers have discovered that cancer cells suppress 'poison exons' -- genetic elements that act as an off switch for protein production -- in a key gene called TRA2 , promoting tumor growth. By ...

Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Erectile dysfunction is common after prostate cancer treatment. A new study shows that aerobic exercise and strength training ...

Investigators assess the impact of increasing persistent PSA levels on prostate cancer–specific mortality and all-cause ...

SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Arjun Pon Avudaiappan discussing survival ...

New research from Edith Cowan University (ECU) has confirmed that erectile dysfunction in patients living with prostate ...

SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Abhi Moolupuri discussing a PET/CT supplemented approach to omission of pelvic lymph node dissection. The National ...